MX2021007551A - Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas. - Google Patents

Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas.

Info

Publication number
MX2021007551A
MX2021007551A MX2021007551A MX2021007551A MX2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A MX 2021007551 A MX2021007551 A MX 2021007551A
Authority
MX
Mexico
Prior art keywords
treatment
sup
neurodegenerative diseases
bile acids
fluorinated
Prior art date
Application number
MX2021007551A
Other languages
English (en)
Inventor
Alexander Charles Weymouth-Wilson
Bruno Jan Pol Linclau
Gemma Packer
Joseph WATTS
Heather Mortiboys
Oliver Bandmann
Christopher Hastings
Original Assignee
Nzp Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nzp Uk Ltd filed Critical Nzp Uk Ltd
Publication of MX2021007551A publication Critical patent/MX2021007551A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de ácido biliar 2-Fluorinado de fórmula general (I) (ver Fórmula) en donde al menos uno de R1 y R2 representa F y el otro se elige 3 de H y F y en donde R3 es como se define en la presente; son de uso en el tratamiento y prevención de trRastornos neurodegenerativos que incluyen enfermedad de Alzheimer y enfermedad de Parkinson.
MX2021007551A 2018-12-20 2019-12-20 Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas. MX2021007551A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1820887.6A GB201820887D0 (en) 2018-12-20 2018-12-20 Compounds
PCT/GB2019/053665 WO2020128514A1 (en) 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
MX2021007551A true MX2021007551A (es) 2021-10-13

Family

ID=65364420

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021007551A MX2021007551A (es) 2018-12-20 2019-12-20 Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas.

Country Status (14)

Country Link
US (1) US20220073557A1 (es)
EP (1) EP3898645A1 (es)
JP (1) JP2022514401A (es)
KR (1) KR20210125982A (es)
CN (1) CN113330020B (es)
AU (1) AU2019411556A1 (es)
BR (1) BR112021011189A2 (es)
CA (1) CA3123333A1 (es)
EA (1) EA202191521A1 (es)
GB (1) GB201820887D0 (es)
IL (1) IL284093A (es)
MX (1) MX2021007551A (es)
SG (1) SG11202105465WA (es)
WO (1) WO2020128514A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202208151D0 (en) 2022-06-01 2022-07-13 Nzp Uk Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934596B1 (fr) * 2008-07-30 2015-04-10 Trophos Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
WO2014036377A1 (en) * 2012-08-31 2014-03-06 Metselex Methods of promoting cell viability
WO2015061421A1 (en) 2013-10-22 2015-04-30 Metselex, Inc. Deuterated bile acids
CN107531741A (zh) * 2015-03-10 2018-01-02 美莱斯股份有限公司 氟化和烷基化胆酸

Also Published As

Publication number Publication date
BR112021011189A2 (pt) 2021-08-31
EP3898645A1 (en) 2021-10-27
JP2022514401A (ja) 2022-02-10
KR20210125982A (ko) 2021-10-19
US20220073557A1 (en) 2022-03-10
IL284093A (en) 2021-08-31
AU2019411556A1 (en) 2021-06-10
WO2020128514A1 (en) 2020-06-25
CN113330020B (zh) 2024-04-05
CN113330020A (zh) 2021-08-31
EA202191521A1 (ru) 2021-09-10
SG11202105465WA (en) 2021-06-29
CA3123333A1 (en) 2020-06-25
GB201820887D0 (en) 2019-02-06

Similar Documents

Publication Publication Date Title
MX2022016276A (es) Nuevos profarmacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson.
PH12018500087A1 (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors
MX2016014634A (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
MX2021004431A (es) Procesos novedosos.
WO2015130842A3 (en) Ether compounds for treatment of complement mediated disorders
MX2019013561A (es) Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos.
WO2009127642A3 (en) Use of lrrk2 inhibitors for neurodegenerative diseases
EA200971050A1 (ru) Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений
UA88634C2 (en) Quaternized quinuclidine esters
EA201990450A1 (ru) Ингибиторы киназы, содержащей домен с двумя лейциновыми "застежками-молниями" (dlk), для лечения заболевания
MX2018004043A (es) Prevencion, tratamiento y reversion de enfermedad usando cantidades terapeuticamente efectivas de acidos grasos activados.
EA200601607A1 (ru) Сульфонамидные соединения для лечения нейродегенеративных расстройств
WO2019075456A3 (en) Methods and substances for prevention and treatment of neurodegenerative diseases
MX2019007102A (es) Derivados de tiazina como inhibidores de beta-secretasa y metodos de uso.
MX2021007161A (es) Agente que contiene acido ursodesoxicolico para tratar o prevenir la presbicia.
MX2021007551A (es) Acidos biliares 2-fluorados para el tratamiento de enfermedades neurodegenerativas.
DE602005007912D1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
MX2010002765A (es) Derivado de 6-pirimidinil-pirimid-4-ona.
MX2020013689A (es) Hidroxipropil-?-ciclodextrina novedosa y proceso para la producción de esta.
RS20080139A (en) Imidazole coumpounds for the treatment of neurological disorders
MX2022011697A (es) Inhibidores de ciclofilina y usos de los mismos.
MX2021011574A (es) Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios.
MX2020005238A (es) Compuestos novedosos como inhibidores mpges-1.
GEP20237493B (en) Use of malonic acid bisamide derivative for treating allergic and other diseases in humans and animals
EP4069315A4 (en) STABILIZATION OF RETROMER FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES